Non-pregnant and non-lactating
Participants who are pregnant or lactating
Is pregnant or lactating
Pregnant or lactating
Not pregnant or lactating, willing to prevent pregnancy while on study and for 6 months after the last dose of XMT-1522
Currently pregnant or lactating
Subject is pregnant or lactating
Lactating or pregnant woman
Patient is pregnant or lactating.
Pregnant or lactating
Subject who is pregnant or lactating.
Not pregnant or lactating
Lactating woman
Pregnant or lactating
EXCLUSION - TREATMENT: Pregnant or lactating
EXCLUSION - INFUSION: Pregnant or lactating
Lactating or pregnant
TREATMENT EXCLUSION: Pregnant or lactating
Lactating or pregnant
Patient is pregnant or lactating
The patient is pregnant or lactating.
Pregnant or lactating
Pregnant or lactating
Pregnant or lactating
Pregnant or lactating.
Pregnant or lactating
Pregnant or lactating
Pregnant or lactating
EXCLUSION - TREATMENT: Pregnant or lactating
If they are pregnant or lactating
Pregnant or lactating, or intending to become pregnant during the study
Pregnant or lactating, or intending to become pregnant during the study
Non-pregnant and non-lactating
Pregnant or lactating, or intending to become pregnant during or within 5 months after the last dose of study treatment Exclusion Criteria Related to Atezolizumab:
Pregnant, lactating, or not using adequate contraception.
Subjects who are pregnant or are lactating
Currently pregnant, lactating or breastfeeding.
Pregnancy and/or lactating.
Pregnant or lactating
Lactating or pregnant
Is pregnant or lactating
DONOR: Pregnant or lactating
Pregnant or lactating, or intending to become pregnant during the study
Lactating or pregnant
Pregnant or lactating
Pregnant or lactating individuals.
Lactating or pregnant
Pregnant or lactating subjects
Be pregnant or lactating
PRIOR TO LYMPHODEPLETION: Pregnant or lactating
Pregnant or lactating individuals.
Subjects must not be pregnant or lactating
Pregnant or lactating
Pregnant or lactating
Subject that is pregnancy or lactating
Pregnant or lactating woman
AT THE TIME OF INFUSION: Pregnant or lactating
Pregnant or lactating
Pregnant or lactating individuals.
Pregnant or lactating
Pregnant or lactating
RECIPIENT: Pregnant or lactating
Pregnant or lactating
Pregnant or lactating.
Pregnant or lactating
Lactating or pregnant
Pregnant or lactating
Pregnant or lactating
Pregnant or lactating
pregnant or lactating
Pregnant or Lactating.
Pregnant or lactating
Pregnant, lactating, or not using adequate contraception
Pregnant, lactating or not using adequate contraception.
Lactating or pregnant
Is pregnant or lactating.
Subjects who are pregnant or lactating;
Non-pregnant and non-lactating.
If they are pregnant or lactating
Who are pregnant and/or lactating
Pregnant or lactating
Pregnant or lactating
Pregnant or lactating, or intending to become pregnant during the study
Subject is pregnant or is lactating
Subject is pregnant or lactating
Pregnant or lactating, or intending to become pregnant during the study
Subject is pregnant or lactating
Pregnant or lactating
Pregnant or lactating
Participant is pregnant or lactating.
The participant is pregnant prior to randomization or lactating.
Subject is pregnant or lactating
Pregnant or lactating
Pregnant or lactating or intending to become pregnant during the study
Participants who are pregnant or lactating
Lactating or pregnant subjects
Lactating or pregnant
Pregnant or lactating.
Lactating or pregnant
Not pregnant or lactating
Are pregnant or lactating.
Pregnant or lactating
Participant is pregnant or lactating
Participants who are pregnant or lactating
Pregnant or lactating
Lactating or pregnant subjects
Currently pregnant or lactating
AT THE TIME OF INFUSION: Pregnant or lactating
Lactating or pregnant.
Subjects who are pregnant or lactating.
Pregnancy and/or lactating
A pregnant or lactating woman.
Pregnant or lactating.
Patient is pregnant or lactating
Pregnant or lactating
Pregnant or lactating
Lactating or pregnant
Pregnant or lactating
Pregnant or lactating
Lactating or pregnant.
Pregnant or lactating
Pregnant or lactating pts
DONOR: not pregnant or lactating
Pregnant or lactating
Pregnant or lactating
Pregnant or lactating
DONOR: Not pregnant or lactating
Pregnant or lactating subjects.
Woman who is pregnant or lactating
Participant is pregnant or lactating
Pregnant or lactating
Subject is pregnant or lactating.
Are pregnant or lactating
Patient is pregnant or lactating
The participant is pregnant or lactating.
Pregnant or lactating
Currently lactating.
Pregnant or lactating
The participant is pregnant or lactating
Self-report of being pregnant or lactating
Subject is pregnant or lactating
Pregnant or lactating
Lactating or pregnant
Lactating or pregnant
Pregnant or lactating
The patient is pregnant or lactating
The subject is known or suspected to be pregnant or lactating
Pregnant or lactating
Pregnant and/or lactating within 1 year prior to screening breast MRI
Must be non-pregnant and non-lactating for at least one year prior to pre-registration
Pregnant or lactating
Lactating
Subjects who are pregnant and/or lactating are not eligible
Not pregnant or lactating and does not intend to become pregnant during the study
Pregnant or lactating
The patient is pregnant or lactating
Subjects who are pregnant or lactating or who suspect they might be pregnant
Subjects who are pregnant or lactating or who suspect they might be pregnant
Subjects who are pregnant or lactating or who suspect they might be pregnant
Patient who is pregnant and/or lactating
Subject is pregnant or lactating
Non-pregnant and non-lactating
Not pregnant or not lactating
Participants who are pregnant, lactating, or who suspect they might be pregnant are not eligible
Pregnant or lactating
Subjects who are pregnant or lactating
Subjects who are pregnant or lactating or who suspect they might be pregnant
The subject is pregnant or lactating.
Subject is pregnant or lactating
The patient is pregnant or lactating.
Pregnant or lactating, or intending to become pregnant during the study
